Dr. Mohit Khera, M.D.
What this data tells you about Dr. Khera
Dr. Mohit Khera is an urology physician in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. Khera performed 3,198 Medicare services across 2,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khera received a total of $392,444 from 27 pharmaceutical and/or device companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone (hormone) level, total | 428 | $25 | $84 |
| Sex hormone binding globulin (protein) level | 419 | $21 | $118 |
| Measurement of total estradiol (hormone) | 374 | $27 | $75 |
| PSA test (prostate cancer screening) | 330 | $18 | $91 |
| Office visit, established patient (20-29 min) | 289 | $64 | $250 |
| Unclassified drugs | 240 | $631 | $2,324 |
| Office visit, established patient (10-19 min) | 191 | $39 | $157 |
| Placement of hormone pellet under skin | 190 | $77 | $479 |
| New patient office visit (30-44 min) | 107 | $74 | $311 |
| Bladder ultrasound after voiding | 106 | $7 | $54 |
| Office visit, established patient (30-39 min) | 96 | $93 | $354 |
| Urinalysis, manual | 70 | $3 | $11 |
| Diagnostic exam of bladder and urethra using an endoscope | 55 | $160 | $1,217 |
| Analysis for detection of tumor marker | 50 | $20 | $43 |
| Psa (prostate specific antigen) measurement, free | 48 | $18 | $91 |
| Electronic assessment of bladder emptying | 35 | $9 | $130 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $37 | $155 |
| Dehydroepiandrosterone (dhea-s) hormone level | 23 | $22 | $96 |
| Gonadotropin, luteinizing (reproductive hormone) level | 23 | $18 | $80 |
| Limited ultrasound scan behind abdominal cavity | 21 | $35 | $200 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 21 | $18 | $80 |
| Prolactin (milk producing hormone) level | 17 | $19 | $78 |
| Ultrasound scan of pelvic region through rectum | 15 | $108 | $387 |
| New patient office visit (45-59 min) | 13 | $111 | $461 |
| Insertion of multicomponent inflatable penile implant | 12 | $663 | $4,062 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khera is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khera experienced with testosterone (hormone) level, total?
Does Dr. Khera receive payments from pharmaceutical companies?
How do Dr. Khera's costs compare to other urology physicians in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology